CTRI/2019/05/019367
Not yet recruiting
Phase 2
Early integrated palliative care versus routine oncological care for advanced adultsarcoma patients in tertiary care center in India: a randomised phase II trial
VIKAS GARG0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- VIKAS GARG
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Subjects with histologically confirmed diagnosis of advanced sarcoma not being treated with curative intent.
- •2\.Diagnosed within the previous 8 weeks.
- •3\.No prior therapy for metastatic disease.
- •4\.Subjects who are willing to provide written informed consent.
- •5\.Ability to understand questions in Hindi or English.
- •6\.Male or female subjects, 18 years of age and older.
Exclusion Criteria
- •1\.Subjects who are already receiving palliative care.
- •2\.Subjects requiring immediate referral to hospice.
- •3\.Subjects with any communication disability, history of or current neurological or psychiatric impairment, or cognitive dysfunction, active brain metastases.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility studyAdvanced Lung CancerJPRN-UMIN000012772ational Cancer Center Hospital East50
Completed
Not Applicable
Early Palliative Care for patients with symptomatic Heart FailureI50.12I50.13I50.14DRKS00013922niklinik BonnMedizinische Klinik II206
Recruiting
Not Applicable
The effect of early palliative care on quality of life and self-care behaviours in patient with type2 diabetesIRCT20231107059976N1Tehran University of Medical Sciences100
Completed
Not Applicable
A randomised phase 3 trial of Palliative care Early in Advanced Lung Cancers.Adults with advanced thoracic malignancy (NSCLC, SCLC orMPM) that have been newly diagnosed within the last 60 days.Adults with advanced thoracic malignancy (NSCLC, SCLC orMPM) that have been newly diagnosed within the last 60 days.Cancer - Lung - Small cellCancer - Lung - Non small cellCancer - Lung - MesotheliomaACTRN12617000166370niversity of Sydney113
Active, not recruiting
Not Applicable
Palliative care with or without palliative chemotherapy: clinical trial.Patients with advanced cancer.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]EUCTR2012-001128-36-ESInstitut de Recerca HSCSP